Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study of Patients Receiving Dupilumab for Chronic Spontaneous Urticaria

NCT07316114 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT07316114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07316114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study of Patients Receiving Dupilumab for Chronic Spontaneous Urticaria
Lead sponsor
Sanofi
Phase
Observational
Overall status
Terminated
Start date
March 18, 2026
Completion date
June 2, 2026
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic spontaneous urticaria